Who owns the GLYPHCBD trademark?

The GLYPHCBD trademark is owned by Seaport Therapeutics, Inc..

What is the serial number for GLYPHCBD?

The USPTO serial number for GLYPHCBD is 99518265.

What is the registration number for GLYPHCBD?

GLYPHCBD is registered under USPTO registration number 0.

GLY

USPTO Trademark Record

PENDING

GLYPHCBD

Q: What class is the GLYPHCBD trademark registered in?

The GLYPHCBD trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 99518265·Reg 0·Filed Nov 26, 2025

Owner Seaport Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

GLYPHCBD (Serial No. 99518265), Registration No. 0, is a pending US trademark filed on Nov 26, 2025 by Seaport Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: March 24, 2027145 days remaining

Mark Intelligence

GLYPHCBD (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 26, 2025

SERIAL

99518265

REG#

Owner

Applicant

Seaport Therapeutics, Inc.

Entity

Corporation

State

Address

101 Seaport Blvd., Floor 12, Boston, MA, 02210

Country

Attorney

NameNicholas B. Hawkins

Law firm

Nicholas B. Hawkins Womble Bond Dickinson (US) LLP

Docket

122621

Address

888 Seventh Avenue, 38th Floor, New York, NY 10106, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateNov 26, 2025

Serial Number99518265

Registration No.0

Status DateSep 22, 2026

Published for OppositionJan 27, 2026

Mark TypeStandard characters

Attorney Docket122621

Status DescriptionLive and pending, first extension granted

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 23, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 22, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Sep 22, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Sep 22, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 24, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 27, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 27, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 21, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 02, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Dec 30, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Nov 26, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 26, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Nov 26, 2025

APPLICATION FILING RECEIPT MAILED

GLYPHCBD

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Seaport Therapeutics, Inc.

Other Marks by Nicholas B. Hawkins

Industries

USPTO Deadlines

Compare

Resources

Company